In: Molecular Imaging and Biology, 2015, vol. 17, no. 5, p. 704-713
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2015, vol. 42, no. 7, p. 1133-1143
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2014, vol. 41, no. 1, p. 68-78
|
In: Child's Nervous System, 2013, vol. 29, no. 3, p. 509-512
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2011, vol. 38, no. 9, p. 1744-1745
|
In: Magnetic Resonance Materials in Physics, Biology and Medicine, 2013, vol. 26, no. 1, p. 57-69
|
In: European Radiology, 2013, vol. 23, no. 12, p. 3393-3404
|
In: The Canadian Journal of Neurological Sciences, 2013, vol. 40, no. 6, p. 800-806
|
In: Parkinsonism & Related Disorders, 2016, vol. 31, p. 53–58
123I-ioflupane SPECT is a powerful method to assess nigrostriatal dopamine system integrity. Several independent studies have shown that 1–15% of patients with suspected degenerative parkinsonism, mainly PD, have scans without evidence of dopaminergic deficit (SWEDD). It has been proposed that most SWEDD patients either present with a non-degenerative condition mimicking PD, such as...
|
In: Molecular Imaging and Biology, 2016, vol. 18, no. 2, p. 302–312
To overcome the issue of reference values for DaTSCAN® requiring healthy controls, we propose an original approach using scans from individuals with non- degenerative conditions performed at one single center following the same acquisition protocol. Procedures: From a cohort of 970 consecutive patients, we identified 182 patients with a clinical diagnosis of non-degenerative parkinsonism or...
|